Manufacturing / Pharmaceutical Preparations
Incannex Healthcare Inc.
IXHL
$3.18
-$0.01 (-0.34%)
Price as of Oct 9, 2026 16:11 UTC
43 M
Market Cap (Micro Cap)
Nov 12
Next Earnings
Technical Signals
as of Oct 7
Bearish
1 of 7
Trend
- Above 20-day average $3.30
- Above 50-day average $3.34
- Above 200-day average $2.60 · +22.5%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) Down · 4d ago
Volume
- Below-average volume 0.3x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Heat Map
Delta-risk grid for IXHL options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
0 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Anastassov George | Other | 1,686,956 | $0 | +814.3% | |
| Nov 14, 2025 | Latham Joel | Other | 22,608,692 | $0 | +814.3% | |
| Nov 14, 2025 | Valentine Troy | Grant | 11,302,608 | $0 | +814.3% | |
| Nov 14, 2025 | Valentine Troy | Other | 11,302,608 | $0 | +814.3% | |
| Nov 14, 2025 | Clark Robert | Other | 1,686,956 | $0 | +814.3% | |
| Nov 14, 2025 | Latham Joel | Grant | 22,608,692 | $0 | +814.3% | |
| Nov 14, 2025 | Widdows Peter | Grant | 1,686,956 | $0 | +814.3% | |
| Nov 14, 2025 | Swan Joseph | Grant | 869,565 | $0 | +814.3% | |
| Nov 14, 2025 | Widdows Peter | Other | 1,686,956 | $0 | +814.3% | |
| Nov 14, 2025 | Swan Joseph | Other | 869,565 | $0 | +814.3% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Sep 28, 2026 | Q4 2026 | -$0.76 | |||
| Jun 30, 2026 | Q4 2026 | -$0.76 | -$0.20 | +74.1% | Beat |
| Mar 31, 2026 | Q3 2026 | -$0.94 | -$11.23 | -1088.4% | Miss |
| Dec 31, 2025 | Q2 2026 | -$0.94 | -$22.83 | -2316.1% | Miss |
| Sep 30, 2025 | Q1 2026 | -$0.94 | -$22.95 | -2328.8% | Miss |
| Jun 30, 2025 | Q4 2025 | -$89.29 | -$15.30 | +82.9% | Beat |
Track IXHL with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for IXHL and your entire portfolio.